GCI

11th November 2024
07:00

Faron Pharma. Oy - Targeting Soluble Clever-1 for Autoimmune Diseases

5th November 2024
07:00

Faron Pharma. Oy - Shareholders’ Nomination Board

22nd October 2024
06:00

Faron Pharma. Oy - Faron’s Capital Markets Day 2024

7th October 2024
06:00

Faron Pharma. Oy - Faron announces Capital Markets Day

30th August 2024
06:00

Faron Pharma. Oy - Grant of options

27th August 2024
06:00

Faron Pharma. Oy - Faron 2024 Half-Year Financial Results

27th August 2024
06:00

Faron Pharma. Oy - FDA Grants Fast Track Designation for Bexmarilimab

20th August 2024
06:00

Faron Pharma. Oy - Notice of Half-Year Financial Results

13th August 2024
06:00

Faron Pharma. Oy - Traumakine Research Collaboration and DoD Grant

8th August 2024
06:00

Faron Pharma. Oy - Appointment of Chief Financial Officer

7th August 2024
09:00

Faron Pharma. Oy - Grant of options

6th August 2024
07:30

Faron Pharma. Oy - Faron Appoints Dr. Petri Bono as new CMO

11th July 2024
06:00

Faron Pharma. Oy - Faron Announces Positive FDA Feedback

25th June 2024
13:00

Faron Pharma. Oy - Update on settlement

25th June 2024
09:30

Faron Pharma. Oy - Holding(s) in Company - Replacement

24th June 2024
11:45

Faron Pharma. Oy - Holding(s) in Company

24th June 2024
11:45

Faron Pharma. Oy - Holding(s) in Company

24th June 2024
11:45

Faron Pharma. Oy - Holding(s) in Company

Faron Pharmaceuticals Oy (FARN.L) Share Price & News

Bid

-

-

-

Ask

High
-
OPEN
-
VOL
-
MKT CAP
-M

LOW
-
CLOSE
-
SHARES IN ISSUE
68.79M

Faron Pharmaceuticals Oy Company Profile

Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs.

Watchlist